Millenium Medical U.S. ad campaign for home-use needle incinerator slated for fall.
This article was originally published in The Gray Sheet
MILLENIUM MEDICAL U.S. AD CAMPAIGN FOR HOME-USE NEEDLE DISPOSAL SYSTEM is slated to begin this fall with print ads in diabetes care publications targeting health care professionals, the firm says. Ontario-based Millenium Medical Supply commenced U.S. shipments of its Needle-Ease 2501 home-use diabetic syringe needle incineration device in March at a list price of $99 following receipt of FDA approval via premarket approval application submission on March 6 ("The Gray Sheet" April 28, p. 16).
You may also be interested in...
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.
As Chinese returnees transform their startups to fully-fledged biopharma operations with a full product lineup and the global market in sight, the journey has been filled with challenges. Based on interviews and on-the-ground reporting, this new series takes a closer look at several companies' experiences.
US FDA Will Need About A Week To Complete COVID Vaccine Assessment Following Advisory Cmte., CBER’s Marks Says
Timeline is the most pessimistic public projection to date, but still incredibly fast. Clinical trial patients on placebo could be contacted and offered the vaccine after an EUA is granted.